Vertical: HealthcareBase Year: 2019
Market Size (2019)
$155.32B
Projected (2027)
$240.84B
CAGR (2017–2027)
5.9%
Key Players
10+
Clinical reference laboratories are used to support diagnosis/analysis in patient care as well as medical research. Laboratory services are an essential part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs and clinical research. The test results, therefore, should be consistent, precise and reproducible. Generation of such quality results includes a stepwise process of thoughtful planning, perfect implementation and thorough checking of results by the whole team involved. International guidelines lay down the principles of a Clinical Reference Laboratory Practices to be monitored by medical researchers to generate quality data but do not address the concerns of reporting quality test results for day-to-day patient care.
The Clinical Reference Laboratory Market market is projected to grow at a CAGR of 5.9% from 2017 to 2027.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansA clinical reference laboratory offers support in terms of diagnosis and analysis for medical research and patient care. These services are an essential part of disease diagnosis, treatment, and monitoring, that aid in the disease surveillance programs and clinical research.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistic agencies, and paid databases. This information creates a base for the study. This information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points that currently affect or are likely to affect the industry over the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation & forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for over the forecast period.
After estimating the market sizes & estimates, numbers are verified with the industry participants and key opinion leaders. The wide network of industry participants performs a value addition in the research and verify the numbers & estimates of the study. In the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The figure below contains the different stages of the whole research performed to produce the report.
DATA MINING
Data mining is one of the extensive stages of our research process. It involves the procurement of market data and related information through different verified & credible sources. This step helps to obtain the raw information about the supply chain of the industry, the monetary process of different end-uses, the pool of market participants & the nature of the industry, and the scope of the study. The data mining stage comprises both primary as well as secondary sources of information.
SECONDARY RESEARCH
In the process of secondary research, various sources are referred to identify and collect industry trends and information for the research process. We at Wantstats have access to some of the most diversified and extensive paid databases which give us the most accurate data/information on market sizes, components, and pricing. Below mentioned is the detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned, we also deploy dynamic access to different other data sources depending on the need for research.
In the primary research process for data mining to analyze the market share of each key player, in-depth primary interviews are conducted with the CXO’s to understand their market share, customer base, pricing strategy, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXO’s of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both supply and demand-side are interviewed to obtain both qualitative as well as quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies are conducted to obtain critical qualitative and quantitative aspects pertaining to the market, as well as to assess the prospects for market growth over the forecast period. The detailed information of these primary respondents is mentioned below in the table
FORECASTING TECHNIQUES
We at Wantstats follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques, as mentioned below.
RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
Understanding the market in terms of valuation is a crucial task. This becomes significantly important while investing in and choosing the correct business opportunities. In this regard, we at Wantstats undertake two market sizing approaches simultaneously, namely, the top-down and bottom-up approaches. In this step, we assess different data points, numeric attributes, information, and industry trends to arrive at the estimates and forecast values for the coming years. We use different mathematical models to estimate the market sizes of different economies and segments, each of which is further summed up to define the total market.
We at Wantstats employ a proprietary statistical tool for market estimations, which helps us to arrive at market size estimates and forecasts for different markets and industries.
BOTTOM-UP APPROACH
In the bottom-up approach, the revenue of key companies and their shares in the market are assessed to deduce the market size. More than 80% of the key players operating in the global clinical reference laboratory market are studied. The segmental revenue of each player is analyzed, and the size for the global clinical reference laboratory market is extracted from the segmental/product revenue with the help of secondary and primary research. The extracted size for the market is then validated with industry experts and partner consultants. This derived market size contributes to around 75% to 80% of the total market share in terms of revenue for the global clinical reference laboratory market. Using the data triangulation method, the overall market size is estimated.
TOP-DOWN APPROACH
The overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research.
The countries considered in the scope of the global clinical reference laboratory market are the US, Canada, Brazil, Argentina, Mexico, Colombia, Chile, Peru, Uruguay, Venezuela, Russia, Poland, the UK, Germany, France, Italy, Spain, Switzerland, Austria, Belgium, Denmark, Finland, Greece, Hungary, Czech Republic, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Slovakia, Sweden, Romania, Ireland, China, Japan, Malaysia, Indonesia, Thailand, Vietnam, the Philippines, South Korea, Pakistan, Singapore, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, Oman, Turkey, and others.
The figure below depicts the process of market estimation using independent tools employed by our analysts to arrive at the sizing of the market.
As a part of the market engineering, both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
DATA TRIANGULATION
After arriving at the overall market sizes, the total market is divided into several segments and sub-segments. Again, the market breakdown and data triangulation procedures are implemented, wherever applicable, to complete the overall market engineering process and gather the exact statistics for all segments and sub-segments. The data is triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size is validated using the top-down and bottom-up approaches.
VALIDATION
Validation is the most important stage of the report making the process. Validation via an intricately designed feedback process helps us finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic and personal interviews, e-mails, feedback forms, questionnaires, and polling options/answers with a group of relevant industry participants. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models, and conclusions.
Base Year
2019
Historical Period
2017 – 2018
Forecast Period
2020 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global clinical reference laboratory market is characterized by the presence of many global, regional, and local vendors catering to the demand created by a large patient pool in need of diagnostic services. The clinical trials required for drug development and new therapy development has given impetus to many diagnostic laboratories to maintain a repository of drug interactions, therapy outcomes and other relevant services. The key players have adopted the strategy of bringing in acquisition for new specialized techniques to perform the clinical trials and medical laboratory testing in the market. The market is highly competitive, with players competing and collaborating to gain a substantial market share. Fragmented market with rising competition, novel service launches, rising collaborative partnerships, and decisions undertaken to achieve operational efficiency are key features of the clinical reference laboratory market. The manufacturers compete based on cost, quality, and reliability of services offered. It is decisive for the manufacturers to provide cost-efficient and innovative services to survive and succeed in an intensely competitive and growing market environment.
The growth of key market players is dependent on market conditions, government support, and industry development. Thus, service providers should focus on expanding geographically and improving their service quality and delivery. They primarily focus on the development of novel business model through vertical and horizontal integration. Although international players are dominating the market; regional, and foreign players with small market shares also have a considerable presence. The international players may strengthen their presence worldwide through acquisitions and collaborations during the forecast period. It has also been forecast that improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new players with innovative service catering capability to enter into the market and increase the global market share.
The global clinical reference laboratory market consists of large number of global and local players operating in the respective regions. Although the market is highly fragmented with no clear leaders in the market, there are few players that have captured significant market share in the global Clinical Reference Laboratory Market.
With respect to the current scope of the report, Laboratory Corporation of America Holdings is observed to be the top player in the global Clinical Reference Laboratory Market owing to its strong service offerings and wide geographic presence. Laboratory Corporation of America Holdings held the 5.6% market share in the global market.
Quest Diagnostics is the second major player with 4.3% share followed by Sonic HealthCare Limited which held 2.2% share in the global clinical reference laboratory market.
Threat of New Entrants
The threat of new entrants is medium in the global clinical reference laboratory market. New players trying to enter the market have to comply with a number of requirements of various regulatory authorities. These regulatory authorities have set standards for services provided by clinical reference laboratories that focus on factors, such as safety, surveillance, and others. These companies need highly qualified medical consultants and trained professionals. However, the budget required for research and development of the medical laboratory services is high as compared to the other industries.
Moreover, if a company desires to survive in the market, it must introduce innovative laboratory services for laboratory testing and disease diagnostic testing, and these innovations require a large amount of investment as well as time. Also, there are very strict government regulations that a company must follow in the market. Additionally, brand loyalty and manufacturing capacity also play major roles in the market. The new entrant has to face huge competition with key players and establishing a brand name in the market is relatively difficult for the new entrants.
Bargaining Power of Suppliers
The bargaining power of suppliers in the clinical reference laboratory market is medium. A high concentration of buyers and their knowledge about the various services also influence the bargaining power of suppliers. The increasing demand from research institutes and entry of multinational clinical reference laboratory companies in the market is further expected to keep the bargaining power of suppliers on a moderate level. Moreover, the presence of a large number of service providers would cater to the needs of the clients, which will lead to intense competition between the existing service providers, which thereby keep the bargaining power of suppliers medium.
Bargaining Power of Buyers
The bargaining power of buyers is medium in the global clinical reference laboratory market, providing the best services at a low rate in the market. The buyers of the clinical reference laboratory are hospitals, clinics, research organizations, and other healthcare organizations. These buyers have a number of choices due to the presence of many services provides in the market. Therefore, such a high concentration of buyers and service providers is increasing the bargaining power of buyers to some extent.
Threat of Substitutes
The threat of substitutes in the global clinical reference laboratory market is low. Any threat from a close substitute product is measured to have a high impact on the market. The threat of substitutes arises when the buyers or the clients in the market can accomplish the end-result using other similar products. Since there is no substitute for clinical laboratory services in the market, thus this decreases the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global clinical reference laboratory market is high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the clinical reference laboratory market are trying to develop cost-effective services to make differentiation in their services. To overcome the competition, players are engaged in developing a process to lower their manufacturing costs. Moreover, the players are also developing advanced techniques for differentiating their services from their rivals, which encourages competition to gain maximum market share.
Market estimates by geography (2027)
InsightAmericas leads with $151.21B by 2027, while Asia Pacific is projected to grow fastest at a 6.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2017 | 2019 | 2027 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $2.97B | $4.09B | $4.70B | 4.7% | 2% |
| Americas | $85.07B | $119.55B | $151.21B | 5.9% | 63% |
| Asia Pacific | $15.11B | $18.78B | $28.26B | 6.5% | 12% |
| Europe | $32.30B | $45.20B | $56.67B | 5.8% | 24% |
| Total | $135.46B | $187.62B | $240.84B | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$240.84B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Hospital-Based | $105.06B | 5.8% | 44% |
| Standalone | $96.72B | 6.6% | 40% |
| Clinic-based | $39.07B | 4.9% | 16% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Clinical Reference Laboratory Market covering market dynamics, competitive landscape, and strategic outlook.
The Clinical Reference Laboratory Market market is projected to reach $240.84B by 2027, growing at 5.9% CAGR. The Hospital-Based segment holds the largest share.
Overview
Clinical reference laboratories are services used to support the diagnosis/analysis in patient care as well as medical research. These laboratory services are an essential part of disease diagnosis, treatment, monitoring response to treatment, and disease surveillance programs. They also serve pharmaceutical and biopharmaceutical companies of all sizes with a range of tests for drug development at both preclinical and clinical stages from the early to late phase.
Prominent factors that drive the market growth are the increasing prevalence of chronic disorders, rising pressure on in-house laboratories of hospitals and clinics, and rising biopharmaceutical drugs in the pipeline. However, high costs of advanced technologies lead to an increase in the costs of specialized tests, which is likely to hamper the growth of the market.
The technological advancement has substantially improved the productivity of clinical laboratories, but the services provided by clinical laboratories are becoming commoditized. Advancement in technologies has led to an increase in the cost of services. With the steadily increasing use of robotics and computerized testing, the services offered by clinical laboratories are increasingly perceived. For some specialized tests, the laboratories have to incur more capital to put more money to purchase the machines and instruments, which may lead to the high costing of specialized tests.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Clinical Reference Laboratory Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Denver, Colorado, US Founded: 1994 Workforce: ~77,000 Company Working: DaVita Inc. (DaVita) consists of two major divisions, the US dialysis & related lab services and ancillary services & strategic initiatives. The US dialysis and related lab services business is a provider of kidney dialysis services in the US for patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company conducts clinical trials for drug and device development customers as well as DaVita’s strategic need to innovate clinical care for patients with ESRD. On June 19, 2019, it completed the sale of the DaVita Medical Group (DMG) business, a patient and physician-focused integrated healthcare delivery and management company, to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. It operates or provides administrative services to a total of 259 outpatient dialysis centers, which includes consolidated and nonconsolidated centers located in ten countries outside the US, serving approximately 28,700 patients.
Company Headquarters: Sydney, Australia Founded: 1987 Workforce: ~ 36,000 Company Working: Sonic Healthcare Limited (Sonic) operates in various segments in the healthcare industry, such as radiology, laboratory medicine/pathology, medical centers/primary care, life screen, occupational and general medicine, clinical trials, and food and water testing. Sonic’s clinical trial segment has one of the most dedicated laboratory segments, which provides a wide range of clinical trial support to pharmaceutical and biotechnological industries. The company operates in countries such as Australia, the US, Germany, Belgium, Switzerland, the UK, Ireland, and New Zealand, and has an employee workforce of around 35,000+ employees globally.
Company Headquarters: London, UK Founded: 2015 Workforce: ~22,000 Company Working: SYNLAB Bondco PLC (SYNLAB) was incorporated on 9 June 2015 and acquired the Labco Group on 7 August 2015 and the Synlab Group on 1 October 2015. The main business of the SYNLAB Bondco PLC is the supply of medical diagnostic services, primarily relating to clinical diagnostics testing, and screening services. It is also active in analytics & services business covering notably environmental and food testing. This company focuses on medical supplies, trade, clinical trials, and offers consulting services. Its customers include doctors, patients, clinics, university hospitals, retirement and nursing homes, veterinary practices, business enterprises, communities and authorities, and pharmaceutical companies. SYNLAB particularly focuses on the implementation of innovative laboratory medicine methods and networking specialist diagnostic competences (SYNLAB Centers of Excellence). SYNLAB maintains its strategic business units in individual countries for veterinary medicine and environmental analysis. This service portfolio is rounded off by expert medical imaging centers in certain countries. The group works closely with research institutions and universities and maintains an educational institution named the SYNLAB Academy. The company is present in more than 37 countries globally. It has a workforce of around 22,000 employees spread across the globe. It performs approximately 450 million test results per annum. It benefits from a network of over 475 laboratories across 37 countries worldwide, including the core markets of Germany, France, Switzerland, Italy, and Spain. It completed 33 acquisitions in 2017 and 21 acquisitions in 2018.
Company Headquarters: New Jersey, US Founded: 1990 Workforce: ~46,000 Company Working: Quest Diagnostics is one of the leading providers of pre-employment drugs-of-abuse screening and risk assessment services for the employers and life insurance industry. It offers physicians a vast test menu and develops new innovative tests. The company majorly provides services in the field of cancer diagnostics, anatomic pathology services, and interpretive consultation. It has two segments, namely, diagnostic information services business (DIS) and diagnostic solutions (DS). The DIS segment complies with about 95% of the net revenue. It serves in the US and selected locations outside the US, such as Mexico, the UK, and India.
Company Headquarters: North Carolina, US Founded: 1978 Workforce: ~70,000+ Company Working: Laboratory Corporation of America Holdings (LabCorp) operates worldwide as an independent clinical laboratory company. It operates through two segments, namely, LabCorp Diagnostics and Covance Drug Development. The company’s product & service portfolio comprises a wide range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures & procedures, and alcohol & other substance-abuse tests. It also offers services to hospitals, physicians, and other healthcare providers and commercial clients to assist in diagnosing, monitoring, and treating diseases and medical conditions by examining substances in the blood, tissues, and other specimens.
Company Headquarters: Geneva, Switzerland Founded: 1987 Workforce: ~12,000 Company Working: Unilabs is one of the leading suppliers of clinical laboratory testing and medical diagnostics imaging services to the public as well as private healthcare providers in Europe. The company provides a wide range of services, which include integrates laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services. It operates laboratory and medical diagnostic imaging facilities in 15 countries (Denmark, France, Italy, UAE, UK, and others).
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
